FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, in particular to operative gynecology and concerns prevention of complications in hysteromyoma patient in case of hysterectomy. For this purpose during 14 days before and 14 days after operation mediation selmevit is introduced perorally. Dose is 1 tablet a day.
EFFECT: performing supravaginal amputation or uterus extirpation against the background of chronic posthemorrhagic anemia, reduction of intraoperative hemorrhage and prevention of DIC syndrome development.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF UTERINE FIBROIDS | 2021 |
|
RU2779190C1 |
| METHOD FOR SURGICAL TREATING UTERINE MYOMA | 2002 |
|
RU2223700C1 |
| METHOD OF SUTURING ABDOMINAL CAVITY AFTER VAGINAL HYSTERECTOMY | 2009 |
|
RU2407468C1 |
| METHOD FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN POST-OPERATIVE PERIOD OF PATIENTS WITH MORBIDITY OBESITY AFTER LAPAROSCOPIC HYSTERECTOMY | 2017 |
|
RU2650975C1 |
| METHOD FOR PREVENTION OF POSTOPERATIVE THROMBOHAEMORRHAGIC COMPLICATIONS IN PATIENTS UNDERGONE HYSTEROMYOMA SURGERY WITH PREOPERATIVE COAGULOGRAM VARIATIONS TO HYPERCOAGULATION | 2013 |
|
RU2534857C1 |
| METHOD FOR TREATING BENIGN TUMORS IN UTERUS | 1998 |
|
RU2137436C1 |
| METHOD FOR PREVENTION OF DEVELOPING GENITAL PROLAPSE FOLLOWING HYSTERECTOMY | 2011 |
|
RU2461826C1 |
| METHOD FOR TRANSRADIAL ENDOVASCULAR EMBOLISATION OF UTERINE ARTERIES | 2014 |
|
RU2551947C1 |
| METHOD OF LAPAROSCOPIC SUPRAVAGINAL ABLATION OF UTERUS | 2007 |
|
RU2343860C1 |
| METHOD OF REMOVAL OF UTERUS FROM ABDOMINAL CAVITY AT PERFORMANCE OF SINGLE-PORT LAPAROSCOPIC SUPRAVAGINAL AMPUTATION OF UTERUS | 2019 |
|
RU2722874C1 |
